AL Amyloidosis: Advancements and Future Trends on Diagnosis and Individualized Treatment Approaches

For the latest developments in the diagnosis and treatment of AL amyloidosis, review a commentary and an on-demand webcast with accompanying downloadable slidesets from a CME-certified satellite symposium.

Share

Program Content

Activities

AL Amyloidosis Key Questions
Key Questions in AL Amyloidosis Care and a Peek Ahead
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 25, 2023

Activities

Management of R/R AL Amyloidosis
Current and Evolving Algorithm for the Management of Relapsed/Refractory AL Amyloidosis
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 07, 2023

Diagnosis and Management of AL Amyloidosis
Diagnostic Approaches & Management Algorithm for Patients With Newly Diagnosed AL Amyloidosis
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 07, 2023

Activities

Managing AL Amyloidosis
AL Amyloidosis: Advancements and Future Trends on Diagnosis and Individualized Treatment Approaches
Video
Congratulations: You achieved a completion on 04/09/2022

Released: December 18, 2023

Expires: December 17, 2024

Faculty

cover img faculity

Angela Dispenzieri, MD

Consultant
Division of Hematology
Serene M. and Frances C. Durling Professor of Medicine and of Laboratory Medicine 
Mayo Clinic
Rochester, Minnesota 

cover img faculity

Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM

Professor of Medicine and Haematology
University College London
Honorary Consultant Haemetologist
University College Hospitals
Director, Jack O’Neil Laboratory
Department of Haematology
National Amyloidosis Centre
London, United Kingdom

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Alexion Pharmaceuticals; Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC; and Prothena Biosciences Limited.

Alexion Pharmaceuticals

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Prothena Biosciences Limited